Search details
1.
Response Evaluation Criteria in PSMA PET/CT (RECIP 1.0) in Metastatic Castration-resistant Prostate Cancer.
Radiology
; 308(1): e222148, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37432081
2.
Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria.
Eur J Nucl Med Mol Imaging
; 49(12): 4271-4281, 2022 Oct.
Article
in English
| MEDLINE | ID: mdl-35767071
3.
Compressed Sensing Radial Sampling MRI of Prostate Perfusion: Utility for Detection of Prostate Cancer.
Radiology
; 290(3): 702-708, 2019 03.
Article
in English
| MEDLINE | ID: mdl-30599102
4.
High 68 Ga-FAPI-46 uptake in a pulmonary necrotizing granuloma in a patient with subcutaneous lipoma.
Eur J Nucl Med Mol Imaging
; 49(3): 1088-1089, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34546387
5.
68Ga-FAPI-46 and 18F-FDG PET/CT in a patient with immune-related thyroiditis induced by immune checkpoint inhibitors.
Eur J Nucl Med Mol Imaging
; 48(11): 3736-3737, 2021 10.
Article
in English
| MEDLINE | ID: mdl-33914106
6.
PET tracers in musculoskeletal disease beyond FDG.
Semin Musculoskelet Radiol
; 18(2): 123-32, 2014 Apr.
Article
in English
| MEDLINE | ID: mdl-24715445
7.
RECIP 1.0 Predicts Progression-Free Survival After [177Lu]Lu-PSMA Radiopharmaceutical Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer.
J Nucl Med
; 65(6): 917-922, 2024 Jun 03.
Article
in English
| MEDLINE | ID: mdl-38637143
8.
Differences and Common Ground in 177Lu-PSMA Radioligand Therapy Practice Patterns: International Survey of 95 Theranostic Centers.
J Nucl Med
; 65(3): 438-445, 2024 Mar 01.
Article
in English
| MEDLINE | ID: mdl-38238041
9.
(18) F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma.
Cancer
; 119(6): 1227-34, 2013 Mar 15.
Article
in English
| MEDLINE | ID: mdl-23233156
10.
Non-oncologic incidental uptake on FAPI PET/CT imaging.
Br J Radiol
; 96(1142): 20220463, 2023 Feb.
Article
in English
| MEDLINE | ID: mdl-35776566
11.
Metal implants on abdominal CT: does split-filter dual-energy CT provide additional value over iterative metal artifact reduction?
Abdom Radiol (NY)
; 48(1): 424-435, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36180598
12.
FAPI PET Signal in Hibernoma Reflects FAP Expression in Tumor Vasculature Cells.
Clin Nucl Med
; 48(7): e353-e355, 2023 Jul 01.
Article
in English
| MEDLINE | ID: mdl-37146173
13.
Fibroblast Activation Protein Expression in Sarcomas.
Sarcoma
; 2023: 2480493, 2023.
Article
in English
| MEDLINE | ID: mdl-37333052
14.
PSMA PET Tumor-to-Salivary Gland Ratio to Predict Response to [177Lu]PSMA Radioligand Therapy: An International Multicenter Retrospective Study.
J Nucl Med
; 64(7): 1024-1029, 2023 07.
Article
in English
| MEDLINE | ID: mdl-36997329
15.
Presurgical 68Ga-PSMA-11 Positron Emission Tomography for Biochemical Recurrence Risk Assessment: A Follow-up Analysis of a Multicenter Prospective Phase 3 Imaging Trial.
Eur Urol
; 84(6): 588-596, 2023 12.
Article
in English
| MEDLINE | ID: mdl-37482512
16.
3'-deoxy-3'-[18F]fluorothymidine positron emission tomography for response assessment in soft tissue sarcoma: a pilot study to correlate imaging findings with tissue thymidine kinase 1 and Ki-67 activity and histopathologic response.
Cancer
; 118(12): 3135-44, 2012 Jun 15.
Article
in English
| MEDLINE | ID: mdl-22020872
17.
Dual-energy CT of acute bowel ischemia.
Abdom Radiol (NY)
; 47(5): 1660-1683, 2022 05.
Article
in English
| MEDLINE | ID: mdl-34191075
18.
18F-FDG PET/CT Imaging Biomarkers for Early and Late Evaluation of Response to First-Line Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma.
J Nucl Med
; 63(2): 199-204, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-34272317
19.
18F-FLT PET/CT as a Prognostic Imaging Biomarker of Disease-Specific Survival in Patients with Primary Soft-Tissue Sarcoma.
J Nucl Med
; 63(5): 708-712, 2022 05.
Article
in English
| MEDLINE | ID: mdl-34593596
20.
Novel Framework for Treatment Response Evaluation Using PSMA PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer (RECIP 1.0): An International Multicenter Study.
J Nucl Med
; 63(11): 1651-1658, 2022 11.
Article
in English
| MEDLINE | ID: mdl-35422442